Zag Bio
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Founded
- 2022
- Business Model
- B2B
- Website
- zagbio.com
- Total Funding
- $80.0M
- Last Round
- $80.0M Series AOct 2025
About
Biotech company developing thymus-targeted bifunctional antibody therapies to restore immune tolerance and treat autoimmune diseases, starting with Type 1 diabetes.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account